Health Care

Q&A with StockPal – Recce Pharmaceuticals (ASX:RCE)



Q&A with StockPal – James Graham, Executive Director of Recce Pharmaceuticals (ASX:RCE)

Watch Jared Sim, Editor-in-Chief and Co-Founder of StockPal and James Graham, Executive Director of Recce Pharmaceuticals (ASX:RCE) in this engaging Q&A with the following questions:

0:11 : How is your company coping throughout the COVID-19 pandemic?
1:09 : When did the company list on the ASX and why?
2:53 : How is your Company funded and what type of economies might investors expect post new-antibiotic approval?
4:26 : Who is the end user and how large/addressable are these patients and their unmet medical needs?
7:35 : What is the competitive advantage of RECCE 327 in comparison to traditional antibiotics?

Visit Recce’s website to learn more about their story:

Want to be on the list next time this company raises capital? Open an account with Fresh Equities and start exploring capital raises –